The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
Open accessAbstract
BACKGROUND: Although much is known about the natural history of systemic lupus erythematosus (SLE), the development of SLE autoantibodies before the diagnosis of the disease has not been extensively explored. We investigated the onset and progression of autoantibody development before the clinical diagnosis. METHODS: The Department of Defense Serum Repository contains approximately 30 million specimens prospectively collected from more than 5 million U.S. Armed Forces personnel. We evaluated serum samples obtained from 130 persons before they received a diagnosis of SLE, along with samples from matched controls. RESULTS: In 115 of the 130 patients with SLE (88 percent), at least one SLE autoantibody tested was present before the diagnosis (up to 9.4 years earlier; mean, 3.3 years). Antinuclear antibodies were present in 78 percent (at a dilution of 1:120 or more), anti-double-stranded DNA antibodies in 55 percent, anti-Ro antibodies in 47 percent, anti-La antibodies in 34 percent, anti-Sm antibodies in 32 percent, anti-nuclear ribonucleoprotein antibodies in 26 percent, and antiphospholipid antibodies in 18 percent. Antinuclear, antiphospholipid antibodies, anti-Ro, and anti-La antibodies were present earlier than anti-Sm and anti-nuclear ribonucleoprotein antibodies (a mean of 3.4 years before the diagnosis vs. 1.2 years, P=0.005). Anti-double-stranded DNA antibodies, with a mean onset 2.2 years before the diagnosis, were found later than antinuclear antibodies (P=0.06) and earlier than anti-nuclear ribonucleoprotein antibodies (P=0.005). For many patients, the earliest available serum sample was positive; therefore, these measures of the average time from the first positive antibody test to the diagnosis are underestimates of the time from the development of antibodies to the diagnosis. Of the 130 initial matched controls, 3.8 percent were positive for one or more autoantibodies. CONCLUSIONS: Autoantibodies are typically present many years before the diagnosis of SLE. Furthermore, the appearance of autoantibodies in patients with SLE tends to follow a predictable course, with a progressive accumulation of specific autoantibodies before the onset of SLE, while patients are still asymptomatic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,406
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,845
SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES
HARVEY, A. M., SHULMAN, L. E., TUMULTY, P. A., CONLEY, C. L., & SCHOENRICH, E. H. (1954) · Medicine · doi:10.1097/00005792-195412000-00001 · Cited by 993
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Wallace, D. J. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-5-436_2 · Cited by 658
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 642
Cited by
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Immune-related adverse events of checkpoint inhibitors
Ramos-Casals, M., Brahmer, J. R., Callahan, M. K., Flores-Chávez, A., Keegan, N., Khamashta, M. A., Lambotte, O., Mariette, X., Prat, A., & Suárez-Almazor, M. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0160-6 · Cited by 1,412
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
New insights into the immunopathogenesis of systemic lupus erythematosus
Tsokos, G. C., Lo, M. S., Reis, P. C., & Sullivan, K. E. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.186 · Cited by 1,226
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1634 · Cited by 1,119
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Müller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., Völkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308917 · Cited by 1,095
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
Competence and competition: the challenge of becoming a long-lived plasma cell
Radbruch, A., Muehlinghaus, G., Luger, E. O., Inamine, A., Smith, K. G. C., Dörner, T., & Hiepe, F. (2006) · Nature Reviews Immunology · doi:10.1038/nri1886 · Cited by 1,030
‘ASIA’ – Autoimmune/inflammatory syndrome induced by adjuvants
Shoenfeld, Y., & Agmon-Levin, N. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.07.003 · Cited by 1,010
D'Cruz, D. P., Khamashta, M. A., & Hughes, G. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60279-7 · Cited by 992
Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules
Labib, M., Sargent, E. H., & Kelley, S. O. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00220 · Cited by 976
Type I Interferon in Systemic Lupus Erythematosus and Other Autoimmune Diseases
Banchereau, J., & Pascual, V. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.010 · Cited by 963
Interaction between the gut microbiome and mucosal immune system
Shi, N., Li, N., Duan, X., & Niu, H. (2017) · Military Medical Research · doi:10.1186/s40779-017-0122-9 · Cited by 940
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Kiriakidou, M., & Ching, C. L. (2020) · Annals of Internal Medicine · doi:10.7326/aitc202006020 · Cited by 821
The immunology of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2021) · Nature Immunology · doi:10.1038/s41590-020-00816-x · Cited by 793
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Banchereau, R., Hong, S., Cantarel, B., Baldwin, N., Baisch, J., Edens, M., Cepika, A.-M., Acs, P., Turner, J., Anguiano, E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.03.008 · Cited by 731
Defective B cell tolerance checkpoints in systemic lupus erythematosus
Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V., & Nussenzweig, M. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042251 · Cited by 717
Simpson, N., Gatenby, P. A., Wilson, A., Malik, S., Fulcher, D. A., Tangye, S. G., Manku, H., Vyse, T. J., Roncador, G., Huttley, G. A., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.25032 · Cited by 684
Genetic Association of the R620W Polymorphism of Protein Tyrosine Phosphatase PTPN22 with Human SLE
Kyogoku, C., Ortmann, W. A., Lee, A., Selby, S., Carlton, V. E. H., Chang, M., Ramos, P., Baechler, E. C., Batliwalla, F. M., Novitzke, J., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423790 · Cited by 672
Pathogenesis of autoimmune disease
Pisetsky, D. S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00720-1 · Cited by 649
Management strategies and future directions for systemic lupus erythematosus in adults
Durcan, L., O'Dwyer, T., & Petri, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30237-5 · Cited by 648
Agmon-Levin, N., Damoiseaux, J., Kallenberg, C., Sack, U., Witte, T., Herold, M., Bossuyt, X., Musset, L., Cervera, R., Plaza-Lopez, A., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203863 · Cited by 615
Criswell, L. A., Pfeiffer, K. A., Lum, R. F., Gonzales, B., Novitzke, J., Kern, M., Moser, K. L., Begovich, A. B., Carlton, V. E. H., Li, W., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429096 · Cited by 602
Immunopathogenic mechanisms of systemic autoimmune disease
Wahren-Herlenius, M., & Dörner, T. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60954-x · Cited by 593
Follicular helper T cells are required for systemic autoimmunity
Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L., Cook, M. C., Walters, G. D., & Vinuesa, C. G. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081886 · Cited by 587
Type I Interferon in the Pathogenesis of Lupus
Crow, M. K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1002795 · Cited by 561
Detecting shared pathogenesis from the shared genetics of immune-related diseases
Zhernakova, A., van Diemen, C. C., & Wijmenga, C. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2489 · Cited by 551
Sokolove, J., Bromberg, R., Deane, K. D., Lahey, L. J., Derber, L. A., Chandra, P. E., Edison, J. D., Gilliland, W. R., Tibshirani, R. J., Norris, J. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035296 · Cited by 516
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Christensen, S. R., Kashgarian, M., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516
Mechanisms of action of mycophenolate mofetil
Allison, A. (2005) · Lupus · doi:10.1177/096120330501400102 · Cited by 480
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States
Satoh, M., Chan, E. K. L., Ho, L. A., Rose, K. M., Parks, C. G., Cohn, R. D., Jusko, T. A., Walker, N. J., Germolec, D. R., Whitt, I. Z., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34380 · Cited by 448
Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry
McClain, M. T., Heinlen, L. D., Dennis, G. J., Roebuck, J., Harley, J. B., & James, J. A. (2005) · Nature Medicine · doi:10.1038/nm1167 · Cited by 441
Self-citationLupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal
Azzouz, D., Omarbekova, A., Heguy, A., Schwudke, D., Gisch, N., Rovin, B. H., Caricchio, R., Buyon, J. P., Alekseyenko, A. V., & Silverman, G. J. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214856 · Cited by 436
Mapping systemic lupus erythematosus heterogeneity at the single-cell level
Nehar-Belaid, D., Hong, S., Marches, R., Chen, G., Bolisetty, M., Baisch, J., Walters, L., Punaro, M., Rossi, R. J., Chung, C.-H., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0743-0 · Cited by 432
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
Stohl, W., Hiepe, F., Latinis, K. M., Thomas, M., Scheinberg, M. A., Clarke, A., Aranow, C., Wellborne, F. R., Abud‐Mendoza, C., Hough, D. R., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34400 · Cited by 418
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
Niewold, T. B., Hua, J., Lehman, T. J. A., Harley, J. B., & Crow, M. K. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364408 · Cited by 416
Self-citationMiklos, D. B., Kim, H. T., Miller, K. H., Guo, L., Zorn, E., Lee, S. J., Hochberg, E. P., Wu, C. J., Alyea, E. P., Cutler, C., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3660 · Cited by 406
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
Casciola-Rosen, L., Nagaraju, K., Plotz, P., Wang, K., Levine, S., Gabrielson, E., Corse, A., & Rosen, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041367 · Cited by 399
Infections and autoimmunity – friends or foes?
Kivity, S., Agmon-Levin, N., Blank, M., & Shoenfeld, Y. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.005 · Cited by 397
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Hiepe, F., Dörner, T., Hauser, A. E., Hoyer, B. F., Mei, H., & Radbruch, A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.1 · Cited by 389
Nature and functions of autoantibodies
Elkon, K., & Casali, P. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0895 · Cited by 388
The impact of the gut microbiome on extra-intestinal autoimmune diseases
Miyauchi, E., Shimokawa, C., Steimle, A., Desai, M. S., & Ohno, H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00727-y · Cited by 367
Nakamura, M., Kondo, H., Mori, T., Komori, A., Matsuyama, M., Ito, M., Takii, Y., Koyabu, M., Yokoyama, T., Migita, K., et al. (2007) · Hepatology · doi:10.1002/hep.21472 · Cited by 365
Genomics and the Multifactorial Nature of Human Autoimmune Disease
Cho, J. H., & Gregersen, P. K. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100030 · Cited by 354
Mysler, E. F., Spindler, A. J., Guzman, R., Bijl, M., Jayne, D., Furie, R. A., Houssiau, F. A., Drappa, J., Close, D., Maciuca, R., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38037 · Cited by 353
Yaniv, G., Twig, G., Shor, D. B.-A., Furer, A., Sherer, Y., Mozes, O., Komisar, O., Slonimsky, E., Klang, E., Lotan, E., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.003 · Cited by 351
Mariz, H. A., Sato, E. I., Barbosa, S. H., Rodrigues, S. H., Dellavance, A., & Andrade, L. E. C. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30084 · Cited by 347
The type I interferon system in systemic lupus erythematosus
Rönnblom, L., Eloranta, M., & Alm, G. V. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21571 · Cited by 341
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Suurmond, J., & Diamond, B. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78084 · Cited by 337
Kiriakidou, M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-7-201310010-01004 · Cited by 333
Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus
Ostendorf, L., Burns, M., Durek, P., Heinz, G. A., Heinrich, F., Garantziotis, P., Enghard, P., Richter, U., Biesen, R., Schneider, U., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2023325 · Cited by 329
B‐lymphocyte contributions to human autoimmune disease
Yanaba, K., Bouaziz, J., Matsushita, T., Magro, C. M., St.Clair, E. W., & Tedder, T. F. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00646.x · Cited by 326
Israeli, E., Grotto, I., Gilburd, B., Balicer, R. D., Goldin, E., Wiik, A., & Shoenfeld, Y. (2005) · Gut · doi:10.1136/gut.2004.060228 · Cited by 322
van der Woude, D., Rantapää-Dahlqvist, S., Ioan-Facsinay, A., Onnekink, C., Schwarte, C. M., Verpoort, K. N., Drijfhout, J. W., Huizinga, T. W. J., Toes, R. E. M., & Pruijn, G. J. M. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.124537 · Cited by 321
Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus
Greiling, T. M., Dehner, C., Chen, X., Hughes, K., Iñiguez, A. J., Boccitto, M., Ruiz, D. Z., Renfroe, S. C., Vieira, S. M., Ruff, W. E., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan2306 · Cited by 320
Hanly, J. G., Urowitz, M. B., Sanchez‐Guerrero, J., Bae, S. C., Gordon, C., Wallace, D. J., Isenberg, D., Alarcón, G. S., Clarke, A., Bernatsky, S., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22305 · Cited by 319
Altered B cell signalling in autoimmunity
Rawlings, D. J., Metzler, G., Wray-Dutra, M., & Jackson, S. W. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.24 · Cited by 308
Type I interferon in the pathogenesis of systemic lupus erythematosus
Postal, M., Vivaldo, J. F., Fernandez-Ruiz, R., Paredes, J. L., Appenzeller, S., & Niewold, T. B. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.10.014 · Cited by 306
The clinical spectrum of autoimmune congenital heart block
Brito-Zerón, P., Izmirly, P. M., Ramos-Casals, M., Buyon, J. P., & Khamashta, M. A. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.29 · Cited by 305
New insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 303
Clinical aspects of autoimmune rheumatic diseases
Goldblatt, F., & O'Neill, S. G. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61499-3 · Cited by 297
Autoimmunity through Cytokine-Induced Dendritic Cell Activation
Banchereau, J., Pascual, V., & Palucka, A. K. (2004) · Immunity · doi:10.1016/s1074-7613(04)00108-6 · Cited by 293
Immunometabolism in early and late stages of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.49 · Cited by 291
Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 287
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus
Poole, B. D., Scofield, R. H., Harley, J. B., & James, J. A. (2006) · Autoimmunity · doi:10.1080/08916930500484849 · Cited by 286
Self-citationZandman-Goddard, G., Shoenfeld, Y., Zandman-Goddard, G., & Shoenfeld, Y. (2005) · Autoimmunity · doi:10.1080/08916930500285352 · Cited by 284
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Cancro, M. P., D’Cruz, D. P., & Khamashta, M. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38010 · Cited by 283
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
Isenberg, D. A., Manson, J. J., Ehrenstein, M. R., & Rahman, A. (2007) · Rheumatology · doi:10.1093/rheumatology/kem112 · Cited by 281
B cells move to centre stage: novel opportunities for autoimmune disease treatment
Browning, J. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2085 · Cited by 279
Autoimmunity and oxidatively modified autoantigens
Kurien, B. T., & Scofield, R. H. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.04.019 · Cited by 268
Self-citationThe complement system in systemic lupus erythematosus: an update
Leffler, J., Bengtsson, A. A., & Blom, A. M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205287 · Cited by 265
Theander, E., Jonsson, R., Sjöström, B., Brokstad, K., Olsson, P., & Henriksson, G. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39214 · Cited by 262
Vaccines, adjuvants and autoimmunity
Guimarães, L. E., Baker, B., Perricone, C., & Shoenfeld, Y. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.08.003 · Cited by 262
Antigen microarray profiling of autoantibodies in rheumatoid arthritis
Hueber, W., Kidd, B. A., Tomooka, B. H., Lee, B. J., Bruce, B., Fries, J. F., Sønderstrup, G., Monach, P., Drijfhout, J. W., van Venrooij, W. J., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21269 · Cited by 261
Tan, F. K., Zhou, X., Mayes, M. D., Gourh, P., Guo, X., Marcum, C., Jin, L., & Arnett, F. C. (2006) · Rheumatology · doi:10.1093/rheumatology/kei244 · Cited by 260
Weckerle, C. E., Franek, B. S., Kelly, J. A., Kumabe, M., Mikolaitis, R. A., Green, S. L., Utset, T. O., Jolly, M., James, J. A., Harley, J. B., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30187 · Cited by 259
Self-citationMunroe, M. E., Lu, R., Zhao, Y. D., Fife, D. A., Robertson, J. M., Guthridge, J. M., Niewold, T. B., Tsokos, G. C., Keith, M. P., Harley, J. B., et al. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208140 · Cited by 256
Self-citationGut Mycobiota in Immunity and Inflammatory Disease
Li, X. V., Leonardi, I., & Iliev, I. D. (2019) · Immunity · doi:10.1016/j.immuni.2019.05.023 · Cited by 246
Xist ribonucleoproteins promote female sex-biased autoimmunity
Dou, D. R., Zhao, Y., Belk, J. A., Zhao, Y., Casey, K. M., Chen, D. C., Li, R., Yu, B., Srinivasan, S., Abe, B. T., et al. (2024) · Cell · doi:10.1016/j.cell.2023.12.037 · Cited by 233
The interferon-α signature of systemic lupus erythematosus
Obermoser, G., & Pascual, V. (2010) · Lupus · doi:10.1177/0961203310371161 · Cited by 220
Clinical Profile and Influences on Outcomes in Patients Hospitalized for Acute Pericarditis
Kytö, V., Sipilä, J., & Rautava, P. (2014) · Circulation · doi:10.1161/circulationaha.114.010376 · Cited by 219
Leuchten, N., Hoyer, A., Brinks, R., Schoels, M., Schneider, M., Smolen, J., Johnson, S. R., Daikh, D., Dörner, T., Aringer, M., et al. (2018) · Arthritis Care & Research · doi:10.1002/acr.23292 · Cited by 190
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis
Wesierska-Gadek, J., Penner, E., Battezzati, P. M., Selmi, C., Zuin, M., Hitchman, E., Worman, H. J., Gershwin, E. M., Podda, M., & Invernizzi, P. (2006) · Hepatology · doi:10.1002/hep.21172 · Cited by 177
Graham, R. R., Ortmann, W., Rodine, P., Espe, K., Langefeld, C., Lange, E., Williams, A., Beck, S., Kyogoku, C., Moser, K., et al. (2007) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201827 · Cited by 174
Self-citationBrimberg, L., Sadiq, A., Gregersen, P. K., & Diamond, B. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.101 · Cited by 172
Ryan, B. J., Nissim, A., & Winyard, P. G. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.004 · Cited by 119
Mechanistic biomarkers for clinical decision making in rheumatic diseases
Robinson, W. H., Lindstrom, T. M., Cheung, R. K., & Sokolove, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.14 · Cited by 109
New tools for classification and monitoring of autoimmune diseases
Maecker, H. T., Lindstrom, T. M., Robinson, W. H., Utz, P. J., Hale, M., Boyd, S. D., Shen-Orr, S. S., & Fathman, C. G. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.66 · Cited by 95
Toward new criteria for systemic lupus erythematosus-a standpoint
Aringer, M., Dörner, T., Leuchten, N., & Johnson, S. R. (2016) · Lupus · doi:10.1177/0961203316644338 · Cited by 93
Baritussio, A., Schiavo, A., Basso, C., Giordani, A. S., Cheng, C., Pontara, E., Cattini, M. G., Bison, E., Gallo, N., De Gaspari, M., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2496 · Cited by 90
Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies
Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D., Heuser, J. S., Gosmanova, A., Rubenstein, C. J., et al. (2008) · Autoimmunity · doi:10.1080/08916930802031579 · Cited by 86
Mummert, E., Fritzler, M. J., Sjöwall, C., Bentow, C., & Mahler, M. (2018) · Journal of Immunological Methods · doi:10.1016/j.jim.2018.05.014 · Cited by 86
Wichainun, R. (2013) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap0272.31.4.2013 · Cited by 82
Metadata
- Authors
- Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H., Dennis, G. J., James, J. A., & Harley, J. B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-10-16
- Volume
- 349
- Issue
- 16
- Pages
- 1526-1533
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2078610240
- Cited by
- 2,578
- References
- 27
- FWCI
- 52.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.